中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Influence of Dehydroxymethylepoxyquinomicin on Radiosensitivity of Thyroid Carcinoma TPC-1 Cells

文献类型:期刊论文

作者Liu, Jie2; Cai, Hu1; Yi, Heqing2; Li, Xin2; Peng, Yunsong3; Li, Linfa2
刊名JOURNAL OF ONCOLOGY
出版日期2022-09-30
卷号2022
ISSN号1687-8450
DOI10.1155/2022/5026308
通讯作者Li, Linfa(pet-ct001@163.com)
英文摘要Objective. To investigate the influence of dehydroxymethylepoxyquinomicin (DHMEQ), an NF-kappa B inhibitor, on radiosensitivity of thyroid carcinoma (TC) TPC-1 cells. Methods. The isolation of CDl33 positive cells (CD133(+) TPC-1) and negative cells (CD133(-) TPC-1) from TPC-1 cells used immunomagnetic bead sorting. After verification of the toxicity of DHMEQ to cells by MTT and cell cloning assays, the cells were divided into four groups, of which three groups were intervened by DHMEQ, I-131 radiation, and DHMEQ +I-131 radiation, respectively, while the fourth group was used as a control without treatment. Alterations in cell growth, apoptosis, and cell cycle were observed. Results. DHMEQ had certain toxic effects on TPC-1 cells, with an IC50 of 38.57 mu g/mL (P < 0.05). DHMEQ inhibited CD133(+) and CD133- TPC-1 proliferation and their clonogenesis after irradiation. DHMEQ + radiation contributed to a growth inhibition rate and an apoptosis rate higher than either or them alone (P < 0.05), with a more significant effect on CD133(-) TPC-1 than CD133+ TPC-1 under the same treatment conditions (P < 0.05). Conclusion. DHEMQ can increase the radiosensitivity of TC cells to I-131, inhibit tumor cell growth, and promote apoptosis. However, its effect is less significant on CD133(+) TPC-1 compared with CD133(-) TPC-1, which may be related to the stem cell-like properties of CD133(+) cells. In the future, the application of DHMEQ in TC 131I radiotherapy will effectively improve the clinical effect of patients.
WOS关键词FACTOR-KAPPA-B ; THERAPEUTIC TARGET ; PROGRESSION ; APOPTOSIS ; INHIBITOR
资助项目Zhejiang medical and health science and technology project ; National Natural Science Foundation of China ; Zhejiang Provincial Medical Health Science and Technology Project ; Zhejiang Provincial Traditional Chinese Medicine Project ; Natural Science Foundation of Zhejiang Province ; [2019KY045] ; [81903982] ; [2018KY296] ; [2016ZB019]
WOS研究方向Oncology
语种英语
WOS记录号WOS:000868325800006
出版者HINDAWI LTD
资助机构Zhejiang medical and health science and technology project ; National Natural Science Foundation of China ; Zhejiang Provincial Medical Health Science and Technology Project ; Zhejiang Provincial Traditional Chinese Medicine Project ; Natural Science Foundation of Zhejiang Province
源URL[http://ir.hfcas.ac.cn:8080/handle/334002/129422]  
专题中国科学院合肥物质科学研究院
通讯作者Li, Linfa
作者单位1.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Inst Basic Med & Canc Chinese, Dept Integrated Tradit Chinese & Western Med,Canc, Hangzhou 310022, Zhejiang, Peoples R China
2.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Inst Basic Med & Canc Chinese, Dept Nucl Med,Canc Hosp, Hangzhou 310022, Zhejiang, Peoples R China
3.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Inst Basic Med & Canc Chinese, Dept Pharm,Canc Hosp, Hangzhou 310022, Zhejiang, Peoples R China
推荐引用方式
GB/T 7714
Liu, Jie,Cai, Hu,Yi, Heqing,et al. Influence of Dehydroxymethylepoxyquinomicin on Radiosensitivity of Thyroid Carcinoma TPC-1 Cells[J]. JOURNAL OF ONCOLOGY,2022,2022.
APA Liu, Jie,Cai, Hu,Yi, Heqing,Li, Xin,Peng, Yunsong,&Li, Linfa.(2022).Influence of Dehydroxymethylepoxyquinomicin on Radiosensitivity of Thyroid Carcinoma TPC-1 Cells.JOURNAL OF ONCOLOGY,2022.
MLA Liu, Jie,et al."Influence of Dehydroxymethylepoxyquinomicin on Radiosensitivity of Thyroid Carcinoma TPC-1 Cells".JOURNAL OF ONCOLOGY 2022(2022).

入库方式: OAI收割

来源:合肥物质科学研究院

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。